Structure and Mapping of the DNA of Human Parvovirus B19

References

1. Anand A., Gray E. S., Brown T., Clewley J. P., Cohen B. J. 1986; Human parvovirus infection in pregnancy and hydrops fetalis. New England Journal of Medicine 316:183–186
   [Google Scholar]
2. Anderson M. J., Jones S. E., Fisher-Hoch S. P., Lewis E., Hall S. M., Bartlett C. L. R., Cohen B. J., Mortimer P. P., Pereira M. S. 1983; The human parvovirus, the cause of erythema infectiosum (fifth disease)?. Lancet i:1378
   [Google Scholar]
3. Astell C. R., Smith M., Chow B., Ward D. C. 1979; Structure of the 3′ hairpin termini of four rodent parvovirus genomes: nucleotide sequence homology at origins of DNA replication. Cell 17:691–703
   [Google Scholar]
4. Bloom M. E., Lechner D., Wiedbrauk D. L., Wolfinbarger J. B. 1987; Analysis of molecularly cloned DNA reveals minor differences among three virus strains of Aleutian disease of mink parvovirus. Archives of Virology 92:175–181
   [Google Scholar]
5. Blundell M. C., Beard C., Astell C. R. 1987; In vitro identification of a B19 parvovirus promoter. Virology 157:534–538
   [Google Scholar]
6. Chorba T., Coccia P., Holman R. C., Tattersall P., Anderson L. J., Sudman J., Young N. S., Kurczynski E., Saarinen U. M., Moir R., Lawrence D. N., Jason J. M., Evatt B. 1986; The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). Journal of Infectious Diseases 154:383–393
   [Google Scholar]
7. Clewley J. P. 1984; Biochemical characterization of a human parvovirus. Journal of General Virology 65:241–245
   [Google Scholar]
8. Cohen B. J., Buckley M. M., Clewley J. P., Jones V. E., Puttick A. H., Jacoby R. K. 1986; Eluman parvovirus infection in early rheumatoid and inflammatory arthritis. Annals of the Rheumatic Diseases 45:832–838
   [Google Scholar]
9. Cossart Y. E., Field A. M., Cant B., Widdows D. 1975; Parvovirus-like particles in human sera. Lancet i:72
   [Google Scholar]
10. Cotmore S. F., Tattersall P. 1984; Characterization and molecular cloning of a human parvovirus genome. Science 226:1161–1165
    [Google Scholar]
11. Courouce A. M., Ferchal F., Morinet F., Muller A., Drouet J., Soulier J. P., Perol Y. 1984; Eluman parvovirus infections in France. Lancet i:160
    [Google Scholar]
12. Davis R. W., Simon M., Davidson N. 1971; Electron microscope heteroduplex methods for mapping regions of base sequence homology in nucleic acids. Methods in Enzymology 21:413–428
    [Google Scholar]
13. Gerry H. W., Kelly T. J. Jr Berns K. I. 1973; Arrangement of nucleotide sequences in adeno-associated virus DNA. Journal of Molecular Biology 79:207–225
    [Google Scholar]
14. Lefrere J. J., Boutard P., Courouce A. M., Lacaze T., Girot R. 1985a; Familial human parvovirus infections. Lancet ii:333–334
    [Google Scholar]
15. Lefrere J. J., Courouce A. M., Muller J. Y., Clark M., Soulier J. P. 1985b; Human parvovirus and purpura. Lancet ii:730
    [Google Scholar]
16. Li Loong T. C., Coyle P. V., Anderson M. J., Allen G. E., Connolly J. H. 1986; Human serum parvovirus associated vasculitis. Postgraduate Medical Journal 62:493–494
    [Google Scholar]
17. Lusby E., Fife K. H., Berns K. I. 1980; Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. Journal of Virology 34:402–409
    [Google Scholar]
18. Morinet F., Tratschin J.-D., Perol Y., Siegl G. 1986; Comparison of 17 isolates of the human parvovirus B19 by restriction enzyme analysis. Archives of Virology 90:165–172
    [Google Scholar]
19. Muller D.-E., Siegl G. 1983; Maturation of parvovirus LuIII in a subcellular system. I. Optimal conditions for in vitro synthesis and encapsidation of viral DNA. Journal of General Virology 64:1043–1054
    [Google Scholar]
20. Nunoue T., Koike T., Koike R., Masayoshi S., Tsukada T., Mortimer P. P., Cohen B. J. 1987; Infection with human parvovirus (B19), aplasia of the bone marrow and a rash in hereditary spherocytosis. Journal of Infection 14:67–70
    [Google Scholar]
21. Okochi K., Mori R., Miyazaki M., Cohen B. J., Mortimer P. P. 1984; Nakatani antigen and human parvovirus (B19). Lancet i:160–161
    [Google Scholar]
22. Pattison J. R., Jones S. E., Hodgson J., Davis L. R., White J. M., Stroud C. E., Murtaza L. 1981; Parvovirus infections and hypoplastic crises in sickle cell anaemia. Lancet i:664–665
    [Google Scholar]
23. Plummer F. A., Hammond G. W., Forward M. D. K., Sekla L., Thompson L. M., Jones S. E., Kidd I. M., Anderson M. J. 1985; An erythema infectiosum-like illness caused by human parvovirus infection. New England Journal of Medicine 313:74–79
    [Google Scholar]
24. Serjeant B. R., Mason K., Topley J. M., Serjeant B. E., Pattison J. R., Jones S. E., Mohamed R. 1981; Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet ii:595–598
    [Google Scholar]
25. Shade R. O., Blundell M. C., Cotmore S. F., Tattersall P., Astell C. R. 1986; Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. Journal of Virology 58:921–936
    [Google Scholar]
26. Shneerson J. M., Mortimer P. P., Vandervelde E. M. 1980; Febrile illness due to a parvovirus. British Medical Journal 280:1580
    [Google Scholar]
27. Summers J., Jones S. E., Anderson M. J. 1983; Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus. Journal of General Virology 64:2527–2532
    [Google Scholar]
28. Wadell G. 1984; Molecular epidemiology of human adenoviruses. Current Topics in Microbiology and Immunology 110:191–220
    [Google Scholar]